alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

118TH CONGRESS 

2D SESSION H. R. 7449 

To amend part A of title IV of the Social Security Act to limit the percentage 

of funds made available for the program of block grants to States 

for temporary assistance for needy families that may be used for administrative expenses, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 23, 2024 

Mrs. STEEL introduced the following bill; which was referred to the Committee 

on Ways and Means 

A BILL 

To amend part A of title IV of the Social Security Act 

to limit the percentage of funds made available for the 

program of block grants to States for temporary assistance for needy families that may be used for administrative expenses, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Reduce Bureaucracy 

5 to Uplift Families Act’’. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7449 IH

1 SEC. 2. LIMITATION ON PERCENTAGE OF FUNDS MADE 

2 AVAILABLE THAT MAY BE USED FOR ADMIN3 ISTRATIVE EXPENSES. 

4 Section 404(b) of the Social Security Act (42 U.S.C. 

5 604(b)) is amended— 

6 (1) in paragraph (1), by striking ‘‘15’’ and in7 serting ‘‘10’’; and 

8 (2) in paragraph (2), by inserting ‘‘, or for case 

9 management needed to assist individuals with devel10 oping an individual responsibility plan pursuant to 

11 section 408(b)’’ before the period. 

12 SEC. 3. LIMITATION ON PERCENTAGE OF QUALIFIED STATE 

13 EXPENDITURES THAT MAY CONSIST OF CER14 TAIN ADMINISTRATIVE EXPENSES. 

15 Section 409(a)(7)(B)(i)(I)(dd) of the Social Security 

16 Act (42 U.S.C. 609(a)(7)(B)(i)(I)(dd)) is amended by 

17 striking ‘‘15’’ and inserting ‘‘10’’. 

18 SEC. 4. EFFECTIVE DATE. 

19 The amendments made by this Act shall take effect 

20 on October 1, 2025. 

21 SEC. 5. TWO-YEAR REAUTHORIZATION OF THE TEMPORARY 

22 ASSISTANCE FOR NEEDY FAMILIES PRO23 GRAM. 

24 Activities authorized by part A of title IV (other than 

25 under section 403(c) or 418) and section 1108(b) of the 

26 Social Security Act shall continue through September 30, 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 7449 IH

1 2026, in the manner authorized for fiscal year 2023, and 

2 out of any money in the Treasury of the United States 

3 not otherwise appropriated, there are hereby appropriated 

4 such sums as may be necessary for such purpose. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
COURT OF APPEALS

SECOND DISTRICT OF TEXAS

FORT WORTH

NO. 02-14-00086-CV 

ROBERT PAUTSKY APPELLANT

V.

GREGORY OHMSTEDE APPELLEE 

------------

FROM THE 78TH DISTRICT COURT OF WICHITA COUNTY

TRIAL COURT NO. 176,057-B

------------

MEMORANDUM OPINION1 AND JUDGMENT

------------

We have considered appellant's “Motion to Dismiss Appeal.” It is the 

court’s opinion that the motion should be granted; therefore, we dismiss the 

appeal. See Tex. R. App. P. 42.1(a)(1), 43.2(f).

Costs of the appeal shall be paid by appellant, for which let execution 

issue. See Tex. R. App. P. 42.1(d).

 

1See Tex. R. App. P. 47.4.
2

PER CURIAM

PANEL: GARDNER, WALKER, and MCCOY, JJ. 

DELIVERED: July 10, 2014
§ 520.2654 Velagliflozin. ( a ) *Specifications.* Each milliliter of solution contains 15 milligrams (mg) velagliflozin.
( b ) *Sponsor.* See No. 000010 in § 510.600(c) of this chapter.
( c ) *Conditions of use* — ( 1 ) *Amount.* Administer orally 0.45 mg per pound of body weight (1 mg per kilogram) velagliflozin once daily.
( 2 ) *Indications for use.* To improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with insulin.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[88 FR 84700, Dec. 6, 2023]
#### Socony-Vacuum Oil Company, Incorporated, *v.*McCray

[No. 17,228.

Filed April 4, 1944.]

*Riley, Reed, Murphy & McAtee,*of East Chicago, for appellant.

*Slaughter & Thorsen,*of Hammond, for appellee.

Flanagan, J.

This is an appeal from an award of the Industrial Board. The only question presented is the sufficiency of the evidence to show a casual connection between the death of appellee’s decedent and the injury which he admittedly sustained while in appellant’s employ.

There is evidence of the following' facts:

The involved injury occurred on Septemer 14, 1942, and consisted of a fracture of the distal phalanx of both *590the large toe and the small toe of the left foot. On October 19, 1942, he returned to his employment as a pipe fitter but he did not feel well, his foot continued to be swollen and hurt him, and he limped. He nevertheless continued working until February 17, 1943, when he went to California to see his son who was in the service. On March 17, 1943, he died on a bus while returning. The undertaker found that the left foot was swollen and cracked, putrefaction had set in and the large toe and instep had a greenish cast. Medical testimony was introduced to the effect that the above described condition of the foot indicated moist gangrene and that the gangrenous condition was necessarily a contributing factor in the cause of death.

Moist gangrene, as a term of general knowledge, means a mortification of a part of the body caused by interference with the local nutrition. It occurs in deep-seated tissues, as in the lung, where evaporation cannot take place, or in the extremities where interference with both arterial and venous circulation has occurred and putrefaction has supervened, as in crushing injuries or compound fractures. See Webster’s New International Dictionary, Second Edition.

In the case before us the nature of the injury and its history support the finding that the gangrene resulted from the injury. The medical testimony was to the effect that the gangrenous condition was necessarily a contributing cause of death. The casual connection between the death of appellee’s decedent and the injury is therefore sufficiently established by the evidence.

Award affirmed with statutory increase of 5 per cent.

Nom — Reported in 53 N. E. (2d) 895.
**Exhibit
32(a)**
 
 **Certification
of Chief Executive Officer Pursuant to 18 U.S.C. § 1350**
 **(Section
906 of the Sarbanes-Oxley Act of 2002)**
 
 Pursuant
to 18 U.S.C. § 1350, the undersigned officer of Republic Bancorp Inc. (the
“Company”) hereby certifies, to such officer’s knowledge, that the Company’s
Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2005 (the
“Report”) fully complies with the requirements of Section 13(a) or 15(d), as
applicable, of the Securities Exchange Act of 1934 and that the information
contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.
 
 
 Date:
      May 6, 2005
    /s/
      Dana M. CluckeyName:
      Dana M. CluckeyTitle:
      President and Chief Executive Officer
 
 The
foregoing certification (i) accompanies the filing and is being furnished solely
pursuant to 18 U.S.C. § 1350, (ii) will not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the
liability of that section, and (iii) will not be deemed to be incorporated by
reference into any filing under the Securities Act of 1933 or the Exchange Act,
except to the extent that the registrant specifically incorporates it by
reference.
 
 
 A signed
original of this written statement required by Section 906, or other document
authenticating, acknowledging, or otherwise adopting the signature that appears
in typed form within the electronic version of this written statement required
by Section 906, has been provided to Republic Bancorp Inc. and will be retained
by Republic Bancorp Inc. and furnished to the Securities and Exchange Commission
or its staff upon request.
#### HILDA AGUILERA, Indiv. and as Special Adm’x of the Estate of Salvador Aguilera, Deceased, and as Mother and Next Friend of Leticia Aguilera, *et al.,*Minors, Plaintiff-Appellant, v. MT. SINAI HOSPITAL MEDICAL CENTER *et al.,*Defendants-Appellees.

First District (4th Division)

No. 1—94—1893

Opinion filed June 27, 1996.
<PAGE>

                                   EXHIBIT 23

               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS


The Board of Directors
First Mariner Bancorp:

We consent to the incorporation by reference in the registration statements
(Nos. 333-60961, 333-60963 and 333-60967) on Form S-8 of First Mariner Bancorp
and subsidiary (First Mariner) of our report dated February 7, 1999, relating
to the consolidated statements of financial condition of First Mariner as of
December 31, 1998 and 1997, and the related consolidated statements of
operations, stockholder's equity and cash flows for each of the years in the
three-year period ended December 31, 1998, which report appears in the December
31, 1998 annual report on Form 10-K of First Mariner.



                                                        /s/
                                                        KPMG LLP





Baltimore, Maryland
March 30, 1999


                                       19
<PAGE>

EXHIBIT 31 (b)

I, Gary Jones certify that:

     1.    I have reviewed this quarterly report on Form 10-Q of Northland Cable
           Properties Seven Limited Partnership;

     2.    Based on my knowledge, this quarterly report does not contain any
           untrue statement of a material fact or omit to state a material fact
           necessary to make the statements made, in light of the circumstances
           under which such statements were made, not misleading with respect to
           the period covered by this quarterly report;

     3.    Based on my knowledge, the financial statements, and other financial
           information included in this quarterly report, fairly present in all
           material respects the financial condition, results of operations and
           cash flows of the registrant as of, and for, the periods presented in
           this quarterly report;



DATE: 8-17-05

/s/ GARY S. JONES
    ---------------------------
    Gary S. Jones
    President
    (Principal Financial and Accounting Officer)
**Exhibit 23.1**
Consent of Independent RegisteredPublic Accounting Firm
     We hereby consent to the incorporation by reference in the RegistrationStatement on Form S-8 (No. 333-128977) of National Atlantic HoldingsCorporation of our report dated March 12, 2007, relating to the consolidatedfinancial statements and consolidated financial statement schedules of NationalAtlantic Holdings Corporation and subsidiaries, and management’s report on theeffectiveness of internal control over financial reporting, which appear inthis Annual Report on Form 10-K of National Atlantic Holdings Corporation forthe year ended December 31, 2006.
/s/ Beard Miller Company LLP                   
Beard Miller Company LLP
[No. 19541-1-II.

Division Two.

December 12, 1997.]

#### The State of Washington, *Respondent,*v. Richard Michael Gibson, *Appellant.*

Appeal from a judgment of the Superior Court for Pierce County, No. 94-1-00345-5, Rosanne Buckner, J., entered May 25, 1995. *Affirmed*by unpublished opinion per Seinfeld, J., concurred in by Houghton, C.J., and Hunt, J.
Exhibit 23  Consent of Independent Registered Public Accounting Firm  The Board of Directors and Stockholders Ballantyne Strong, Inc.:  We consent to the incorporation by reference in the registration statements (File Nos. 333-03849, 333-116739, 333-139177, and 333-153408) on Form S-8 of Ballantyne Strong, Inc. (the Company) of our reports dated March 16, 2011 with respect to the consolidated balance sheets of Ballantyne Strong, Inc. and subsidiaries as of December 31, 2010 and 2009, and the related consolidated statements of operations, stockholders equity and comprehensive income (loss), and cash flows for each of the years in the three-year period ended December 31, 2010, and the related financial statement schedule II, and the effectiveness of internal control over financial reporting as of December 31, 2010, which reports appear in the Annual Report on Form 10-K of Ballantyne Strong, Inc. for the year ended December 31, 2010.  /s/ KPMG LLP Omaha, Nebraska March 16, 2011
# C_2014135EN.01002101.xml

| 5.5.2014 | EN | Official Journal of the European Union | C 135/21 |
| --- | --- | --- | --- |

5.5.2014

EN

Official Journal of the European Union

C 135/21

---

Request for a preliminary ruling from the Rechtbank van eerste aanleg te Turnhout (Belgium) lodged on 5 February 2014 — Openbaar Ministerie v Marc Emiel Melanie De Beuckeleer and Others

(Case C-56/14)

2014/C 135/24

Language of the case: Dutch

Referring court

Referring court

Rechtbank van eerste aanleg te Turnhout

Parties to the main proceedings

Parties to the main proceedings

Applicant: Openbaar Ministerie

Applicant:

Defendants: Marc Emiel Melanie De Beuckeleer, Michiel Martinus Zeeuws, Staalbeton NV/SA

Defendants:

Question referred

Question referred

Is the prior declaration requirement for employees imposed under the LIMOSA system, as provided for in Articles 137 to 152 of the Belgian Programme Law of 27 December 2006, incompatible with the freedom to provide services guaranteed by Article 49 EC and Article 56 TFEU?

---
Exhibit 99.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report on Form 10-Q of Factory 2-U Stores, Inc.
(the "Company") for the quarter ended May 3, 2003, as filed with the Securities
Exchange Commission on the date hereof (the "Report"), I, William R. Fields,
Chief Executive Officer of the Company, certify, pursuant to and for purposes of
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

(1)  The Report fully complies with the  requirements of Section 13(a) or 15 (d)
     of the Securities Exchange Act of 1934; and

(2)  The information  contained in the Report fairly  presents,  in all material
     aspects,  the financial  condition of the Company as of the dates indicated
     and result of operations of the Company for the periods indicated.




                                              /s/ William R. Fields
                                              ---------------------
                                              William R. Fields
                                              Chief Executive Officer
                                              June 17, 2003
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 101 Introduced in Senate (IS)]

109th CONGRESS
  1st Session
                                 S. 101

 To convey to the town of Frannie, Wyoming, certain land withdrawn by 
                    the Commissioner of Reclamation.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 24, 2005

   Mr. Enzi introduced the following bill; which was read twice and 
       referred to the Committee on Energy and Natural Resources

_______________________________________________________________________

                                 A BILL

 
 To convey to the town of Frannie, Wyoming, certain land withdrawn by 
                    the Commissioner of Reclamation.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CONVEYANCE OF LAND TO THE TOWN OF FRANNIE, WYOMING.

    (a) Conveyance.--Subject to valid existing rights, the Secretary of 
the Interior shall convey by quitclaim deed, without consideration, all 
right, title, and interest of the United States in and to the parcel of 
land described in subsection (b) to the town of Frannie, Wyoming.
    (b) Description of Land.--The parcel of land referred to in 
subsection (a) is the parcel of land withdrawn by the Commissioner of 
Reclamation--
            (1) consisting of approximately 37,500 square feet;
            (2) located in the town of Frannie, Wyoming; and
            (3) more particularly described in the approved Plat of 
        Survey of Frannie Townsite, Wyoming, as the North \1/2\ of 
        Block 26, T. 58 N, R. 97 W.
    (c) Reservation of Mineral Rights.--The conveyance under subsection 
(a) shall be subject to the reservation by the United States of any oil 
and gas rights.
    (d) Revocations.--
            (1) Special use permit.--The special use permit issued by 
        the Commissioner of Reclamation, numbered O-LM-60-L1413, and 
        dated April 20, 1990, is revoked with respect to the land 
        described in subsection (b).
            (2) Secretarial orders.--The following Secretarial Orders 
        issued by the Commissioner of Reclamation are revoked with 
        respect to the land described in subsection (b):
                    (A) The Secretarial Order for the withdrawal of 
                land for the Shoshone Reclamation Project dated October 
                21, 1913, as amended.
                    (B) The Secretarial Order for the withdrawal of 
                land for the Frannie Townsite Reservation dated April 
                19, 1920.
                                 <all>
```
-       - Superintendent of Documents
      - 2023-09-01T20:30:45-0400
      - Government Publishing Office, Washington, DC 20401
      - Government Publishing Office
      - Government Publishing Office attests that this document has not been altered since it was disseminated by Government Publishing Office
§ 251.4 Review and authorization of importation program proposals. Based on a review of a SIP Proposal or supplemental proposal submitted under this part, FDA may authorize a SIP, modify a SIP, or extend the authorization period of a SIP, that meets the requirements of this part. FDA may use a phased review process to review a SIP Proposal that does not identify a Foreign Seller in an initial submission, under which FDA may notify the Sponsor of such a SIP Proposal whether the Sponsor's SIP Proposal otherwise meets the requirements of this part. In such a case, the required information regarding importers, relabelers, and repackagers still must be included in the initial submission of the SIP Proposal, and the SIP Proposal will be denied if a Foreign Seller is not identified within 6 months of the initial submission date of the SIP Proposal. ( a ) FDA may deny a request for authorization, modification, or extension of a SIP, including if a SIP Proposal or supplemental proposal does not meet the requirements of this part. When a SIP Proposal or supplemental proposal meets the requirements of this part, FDA may nonetheless decide not to authorize the SIP Proposal or supplemental proposal. For example, FDA may decide not to authorize a SIP Proposal or supplemental proposal because of potential safety concerns with the SIP; because a Foreign Seller is not identified within 6 months of the initial submission of the SIP Proposal; because of the degree of uncertainty that the SIP Proposal or supplemental proposal would adequately ensure the protection of public health; because of, based on the recommendation of another Department of Health and Human Services (HHS) component as directed by the Secretary, the relative likelihood that the SIP Proposal or supplemental proposal would not result in significant cost savings to the American consumer; because of the potential for conflicts of interest; or in order to limit the number of authorized SIPs so FDA can effectively and efficiently carry out its responsibilities under section 804 of the Federal Food, Drug, and Cosmetic Act in light of the amount of resources allocated to carrying out such responsibilities.
( b ) FDA will notify a SIP Sponsor in writing when FDA receives the SIP Sponsor's SIP Proposal or supplemental proposal.
( c ) FDA will make a reasonable effort to promptly communicate to a SIP Sponsor about any information required by § 251.3 that was not submitted in a SIP Proposal. ( 1 ) FDA may notify a SIP Sponsor if FDA believes additional information would help FDA's review of a SIP Proposal or supplemental proposal.
( 2 ) FDA will notify a SIP Sponsor in writing whether FDA has decided to authorize or not to authorize the SIP Sponsor's SIP Proposal or supplemental proposal.
### -78.5 -78.0 -77.5 -77.0 -76.5 -76.0 -75.5

38.0 38.5 39.0 39.5 40.0 

## ★

▲ ▲ ▲ ▲


## ★ ▲ ▲ ▲ ▲ 

### 500 1000 1500 100 18 12 06 00 08/12 

## NOAA HYSPLIT MODEL 

# Backward trajectory ending at 2300 UTC 12 Aug 07

EDAS Meteorological DataSource★at 39.41 N 76.30 WMeters AGL 

## ★ ■ ■ ■



## ★ ■ ■ ■ ■ 

## ★ ● ●



## ★ ● ● ● ●
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   YEAR                   9-MOS
<FISCAL-YEAR-END>                          JAN-31-1997             JAN-31-1998
<PERIOD-START>                             FEB-01-1996             FEB-01-1997
<PERIOD-END>                               JAN-31-1997             OCT-31-1997
<CASH>                                         198,317               1,925,029
<SECURITIES>                                         0               1,584,576
<RECEIVABLES>                                  476,766               1,244,955
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                               715,711               5,088,341
<PP&E>                                         142,812                 320,865
<DEPRECIATION>                                  61,985                 121,733
<TOTAL-ASSETS>                                 868,537               7,850,019
<CURRENT-LIABILITIES>                          413,983               1,052,654
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                    239,918                       0
<COMMON>                                        75,000               6,546,376
<OTHER-SE>                                     139,636                 250,989
<TOTAL-LIABILITY-AND-EQUITY>                   868,537               7,850,019
<SALES>                                      1,485,869               2,565,545
<TOTAL-REVENUES>                             1,485,869               2,565,545
<CGS>                                          774,242               1,700,797
<TOTAL-COSTS>                                  774,242               1,700,797
<OTHER-EXPENSES>                               514,059                 676,753
<LOSS-PROVISION>                                     0                       0
[INTEREST-INCOME]                                    0                  72,236
<INTEREST-EXPENSE>                               8,840                  31,481
<INCOME-PRETAX>                                188,728                 228,750
<INCOME-TAX>                                    64,454                  77,821
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                   124,274                 150,929
<EPS-PRIMARY>                                     0.11                    0.10
<EPS-DILUTED>                                     0.11                    0.10
        

</TABLE>